Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

Kongfei Li(Zhejiang University), Hongyan Tong(First Affiliated Hospital Zhejiang University)
Journal of Translational Medicine
June 12, 2014
Cited by 48


Related Papers